These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6367854)

  • 1. Quality control of estrogen receptor assays in The Netherlands.
    Koenders T; Benraad TJ
    Breast Cancer Res Treat; 1983; 3(3):255-66. PubMed ID: 6367854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of steroid receptor assays in human breast cancer--I. Reproducibility of estradiol and progesterone receptor assays.
    Koenders A; Thorpe SM
    Eur J Cancer Clin Oncol; 1983 Sep; 19(9):1221-9. PubMed ID: 6684569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol receptor activity in lyophilized calf uterus and human breast tumor tissue.
    Benraad T; Koenders A
    Cancer; 1980 Dec; 46(12 Suppl):2762-4. PubMed ID: 7448716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality control for estrogen receptor quantification by dextran-coated charcoal assay: a single laboratory's experience.
    Raam S; Gelman R; Faulkner J; White GM; Cohen JL
    Breast Cancer Res Treat; 1982; 2(1):111-7. PubMed ID: 6184100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of steroid receptor assays in human breast cancer--III. Selection of reference material for intra- and inter-laboratory quality control.
    Thorpe SM; Koenders A
    Eur J Cancer Clin Oncol; 1986 Aug; 22(8):939-44. PubMed ID: 3770051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols.
    Ryan ED; Clark AF; Mobbs BG; Ooi TC; Sutherland DJ; Tustanoff ER
    Clin Biochem; 1985 Feb; 18(1):20-6. PubMed ID: 3986988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of steroid receptor assays in human breast cancer--II. Samples with low receptor content.
    Koenders A; Thorpe SM
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1467-72. PubMed ID: 6685633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols.
    Goussard J; Lechevrel C; Martin PM; Roussel G
    Cancer Res; 1986 Aug; 46(8 Suppl):4282s-4287s. PubMed ID: 2425945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls in the Dextran-coated charcoal assay of estrogen receptors in breast cancer tissue.
    Pettersson KS; Vanharanta RM; Söderholm JR
    J Steroid Biochem; 1985 Jan; 22(1):39-45. PubMed ID: 2579292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control program of steroid receptor assays: an international study.
    Vermousek I; Számel I; Goerlich M; Brdar B; Cvrtila D; Graf D; Padovan R; Paszko Z; Safarcík K
    Neoplasma; 1992; 39(1):65-9. PubMed ID: 1382235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control study of estradiol and progesterone receptor determination.
    Vermousek I; Számel I
    Neoplasma; 1988; 35(3):307-14. PubMed ID: 3405339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control study for estradiol receptor determination.
    Számel I; Vermousek I
    Arch Geschwulstforsch; 1985; 55(3):187-92. PubMed ID: 4026532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assays.
    Zava DT; Wyler-von Ballmoos A; Goldhirsch A; Roos W; Takahashi A; Eppenberger U; Arrenbrecht S; Martz G; Losa G; Gomez F; Guelpa C
    Eur J Cancer Clin Oncol; 1982 Aug; 18(8):713-21. PubMed ID: 6891322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of coated charcoal in the determination of oestrogen receptor activity.
    Ralet PG; Brombacher PJ
    Eur J Nucl Med; 1981 Apr; 6(4):159-62. PubMed ID: 7215381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of estrogen and progesterone receptor assays.
    Chua D; Aw SE; Chan SH; Oon CJ
    Ann Acad Med Singap; 1986 Oct; 15(4):492-7. PubMed ID: 3566169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor and alpha-fetoprotein in human breast cancer: brief communication.
    Nakao K; Ochi H; Kawashima M; Tomino S; Sugano H; Matsumoto K
    J Natl Cancer Inst; 1978 Feb; 60(2):289-90. PubMed ID: 74414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lyophilization on steroid receptor behavior, as defined by sucrose density gradient analysis.
    Janes GR; Koenders AJ; Benraad TJ
    J Steroid Biochem; 1982 Oct; 17(4):387-94. PubMed ID: 7132353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.
    Leclercq G; Bojar H; Goussard J; Nicholson RI; Pichon MF; Piffanelli A; Pousette A; Thorpe S; Lonsdorfer M
    Cancer Res; 1986 Aug; 46(8 Suppl):4233s-4236s. PubMed ID: 2425942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.
    Thorpe SM
    Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision in estrogen and progesterone receptor assays. Results of the first CAP pilot survey.
    Oxley DK; Haven GT; Wittliff JL; Gilbo D
    Am J Clin Pathol; 1982 Oct; 78(4 Suppl):587-96. PubMed ID: 7137099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.